As an initial convening, Our Stories Rx is hosting a virtual roundtable conversation with Antonio Ciaccia, who served as the government affairs director for the Ohio Pharmacists Association in 2018, when a state audit revealed a PBM-led spread pricing scheme
Online Registration Is Closed
Washington Rheumatology Alliance’s 14th Annual Conference September 17-19, 2021 Sleeping Lady Mountain Resort 7375 Icicle Road Leavenworth, WA 98826 Online registration is now closed. Onsite registration will be available; please contact Sleeping Lady directly regarding room availability. Your registration includes the
New Medicare Changes
We are providing information that hopefully will help our members understand the 2021 Final WRVU billing codes and reimbursements slated for Rheumatologists. The final WRVU code values for E & M coding: Please notice that at the end of 2020,
2020 Salary Survey
Dear colleagues, It has come to my attention that many of the hospital systems are not compensating rheumatologists for any increase in RVU value that CMS has just put in place starting January 1 to help compensate for cognitive specialists
Save the Date for WRA’s 14th Annual Conference September 17-19, 2021
Dear colleagues, The Washington Rheumatology Alliance cordially invites you to join us for our outstanding annual conference September 17-19, 2021, which will be held again at the intimate Sleeping Lady Mountain Resort in the beautiful Cascade Mountains of Washington State.
Genentech Stance on Most Favored Nations (MFN) Model
On December 15, 2020, Genentech led a discussion about how the Most Favored Nations (MFN) model threatens provider and patient access to existing and future medicines; we share your concerns that this could have a detrimental impact on your practice
Downloadable Resources from the Arthritis Foundation
The Arthritis Foundation has free downloadable brochures and fact sheets through the AF Store that you can save to your office desktop. The brochures and fact sheets can be e-mailed to patients or you can print copies in-office and hand
Biosimilars Could Generate $100 Billion in Savings Over Next Five Years, New Report Finds
WASHINGTON, D.C. — A new report from the IQVIA Institute for Human Data Science has determined that biosimilars are on track to reduce drug costs by $100 billion over the next five years if their use rises. The future of this lower-cost
Coronavirus: What Chronic Illness Patients Need to Know
From CreakyJoints: We’ve been hearing many questions and concerns from our global patient community about the continued spread of coronavirus across the U.S. and around the world. And while people with disabilities and chronic diseases have even more of a
Regence Rituxan to Ruxience has been Reversed
Regence Policy Reversed: The decision from Regence to mandate the switch from Rituxan patients to Ruxience has been reversed and Regence will approve Rituxan patients currently on treatment to continue for 1 year. If you have already submitted the authorization